Cromos Pharma is a US-based international CRO with expertise in delivering all aspects of clinical trials in all clinical phases across a wide range of therapeutic areas. Cromos Pharma offers fully integrated CRO services including regulatory consulting and compliance, project management; monitoring; medical writing; data management and biostatistics; drug and device registration services; logistics and warehousing; post-marketing services and independent audits. Cromos Pharma delivers rapid recruitment and excellent patient retention as well as expert study design and management.We combine global expertise with in-depth experience and knowledge in Central and Eastern Europe to offer exceptional patient recruitment. In our 16 year history, our team has met or reduced enrollment timelines in 95% of trials conducted. Responsible recruitment is supported by our "No Patients-No Payments" initiative – a unique risk-sharing program. We provide the most optimized start-up timelines in our regions. We regularly achieve regulatory approvals in Georgia, within two months of project signing (4 months in Russia, and in less than 5 in Ukraine). Regulatory inspections and site audits also attest to the highest quality of our clinical data: EMA in 2019 (1-week oncology site inspection); FDA in 2017 (2-week oncology site inspection). Established in Portland, Oregon in 2004, Cromos Pharma has operations in over 15 countries worldwide including the US, Hungary, Poland, Czech Republic, Russia, and Georgia.